Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer

NDAQ:APHA - Post by User

Aphria Inc.

Bullboard Posts

Comment by premium54on Jan 19, 2017 7:37am

115 Views

Post# 25726718

RE:RE:RE:RE:IIROC Trading Halt - KALY

Positive results from the study, but... "the GvHD market was valued at $295M across the six major markets in 2013, and is expected to grow to $544M by 2023, according to the research and consulting firm

Why wouldnt they have 100% of the market. There is no other drug doing this.

Bullboard Posts

Investor’s corner: Solving chronic pain in dogs – A significant market opportunity